Jasper Rikkert Plaisier

Introduction: Jasper Rikkert Plaisier, an accomplished inventor from Tricesimo, Italy, has made significant contributions to the field of scientific research through his innovative work. With a focus on the pharmaceutical sector, he is recognized for developing a unique method that advances the detection of polymorphs, which are essential in understanding the properties of drug compounds.

Latest Patents: Plaisier holds one patent titled "Method of detecting polymorphs using synchrotron radiation." This groundbreaking method involves detecting polymorphs using X-rays produced by a synchrotron source. It is particularly beneficial for identifying specific polymorphs present in small quantities within mixtures of polymorphic compounds, offering high-resolution analysis that is crucial in pharmaceutical applications.

Career Highlights: Plaisier is associated with Zetacube S.r.l., where he continues to push the boundaries of innovation in his field. His work has established new methodologies that aid in the identification and investigation of various polymorphs, enhancing the potential for drug formulation and effectiveness.

Collaborations: Throughout his career, Plaisier has worked alongside talented colleagues, including Roberto Brescello and Livius Cotarca. Their collaborative efforts have contributed to the advancement of technology and research in the domain of pharmaceutical sciences, fostering a culture of innovation within their organization.

Conclusion: With his patent and ongoing research, Jasper Rikkert Plaisier exemplifies the spirit of innovation. His contributions are not only significant for their scientific merit but also for their practical applications in the pharmaceutical industry. As he continues to explore new frontiers in detection methodologies, the impact of his work will undoubtedly resonate within the fields of research and development.

Profile summary based on public USPTO records.